<SEC-DOCUMENT>0001387131-23-007603-index.html : 20230616 <SEC-HEADER>0001387131-23-007603.hdr.sgml : 20230616 <ACCEPTANCE-DATETIME>20230615182147 ACCESSION NUMBER: 0001387131-23-007603 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20230524 ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230616 DATE AS OF CHANGE: 20230615 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Adamis Pharmaceuticals Corp CENTRAL INDEX KEY: 0000887247 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820429727 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36242 FILM NUMBER: 231018854 BUSINESS ADDRESS: STREET 1: 11682 EL CAMINO REAL STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 997-2400 MAIL ADDRESS: STREET 1: 11682 EL CAMINO REAL STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: CELLEGY PHARMACEUTICALS INC DATE OF NAME CHANGE: 19950615 </SEC-HEADER> <DOCUMENT> <TYPE>8-K/A <SEQUENCE>1 <FILENAME>admp-8ka_052423.htm <DESCRIPTION>AMENDMENT TO FORM 8-K <TEXT> Document 1 - file: admp-8ka_052423.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>2 <FILENAME>ex23-1.htm <DESCRIPTION>CONSENT OF BF BORGERS CPA PC. <TEXT> Document 2 - file: ex23-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>3 <FILENAME>ex99-1.htm <DESCRIPTION>AUDITED FINANCIAL STATEMENTS OF DMK PHARMACEUTICALS <TEXT> Document 3 - file: ex99-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.2 <SEQUENCE>4 <FILENAME>ex99-2.htm <DESCRIPTION>UNAUDITED FINANCIAL STATEMENTS OF DMK PHARMACEUTICALS <TEXT> Document 4 - file: ex99-2.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.3 <SEQUENCE>5 <FILENAME>ex99-3.htm <DESCRIPTION>UNAUDITED PRO FORMA CONDENSED COMBINED CONSOLIDATED FINANCIAL INFORMATION <TEXT> Document 5 - file: ex99-3.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.SCH <SEQUENCE>6 <FILENAME>admp-20230525.xsd <DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT <TEXT> Document 6 - file: admp-20230525.xsd
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.LAB <SEQUENCE>7 <FILENAME>admp-20230525_lab.xml <DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT <TEXT> Document 7 - file: admp-20230525_lab.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.PRE <SEQUENCE>8 <FILENAME>admp-20230525_pre.xml <DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT <TEXT> Document 8 - file: admp-20230525_pre.xml
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>9 <FILENAME>R1.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 9 - file: R1.htm
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>10 <FILENAME>admp-8ka_052423_htm.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 10 - file: admp-8ka_052423_htm.html
Document 10 - RAW XML: admp-8ka_052423_htm.xml
</DOCUMENT> <DOCUMENT> <TYPE>EXCEL <SEQUENCE>11 <FILENAME>Financial_Report.xlsx <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 11 - file: Financial_Report.xlsx
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>12 <FILENAME>Show.js <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 12 - file: Show.js
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>13 <FILENAME>report.css <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 13 - file: report.css
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>14 <FILENAME>FilingSummary.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 14 - file: FilingSummary.html
Document 14 - RAW XML: FilingSummary.xml
</DOCUMENT> <DOCUMENT> <TYPE>JSON <SEQUENCE>16 <FILENAME>MetaLinks.json <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 16 - file: MetaLinks.json
</DOCUMENT> <DOCUMENT> <TYPE>ZIP <SEQUENCE>17 <FILENAME>0001387131-23-007603-xbrl.zip <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 17 - file: 0001387131-23-007603-xbrl.zip
</DOCUMENT> </SEC-DOCUMENT>